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Background and purpose of the study: The aim of this study was to investigate the effect of cinnamaldehyde on
mucositis and salivary total antioxidant capacity in gamma-irradiated rats.
Methods: The study was conducted on 28 male Wistar rats, 7–11 weeks of age and 160 ± 20 g body weight,
divided into four groups of seven rats each. The first group receiving normal saline (S), the second group receiving
saline and gamma radiation (SR), the third group receiving 50 mg/kg cinnamaldehyde 98% (C), and the fourth
group receiving 50 mg/kg cinnamaldehyde 98% and gamma radiation (CR). SR and CR groups were exposed to
15 Gy gamma irradiation for 7 min and 39 s. Rats were intraperitoneally injected each day during the 10-day period
of the experiment, and their tongues and lips were examined to assess the incidence and severity of mucositis. The
saliva samples were taken from the animals three times on day zero, six, and ten.
Results: The mean mucositis incidence appeared to be delayed in the CR than the SR group (P = 0.024), and the
severity was significantly higher in the SR compared to the CR group;the difference was statistically significant on
the second day (P = 0.027). In the evaluation of salivary antioxidant capacity, salivary antioxidant concentration was
significantly higher in the C than the S, SR, and CR groups on the tenth day of the experiment (p <0.05).
Conclusion: The clinical effects in the CR group seem to be due to antioxidant, anti-bacterial and anti-inflammatory
effects of cinnamaldehyde; this conclusion, however, requires further investigations. Delayed antioxidant effect in
the CR group was evident in ip cinnamaldehyde injection, the exact mechanism is not clear.
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Oral mucositis is the most common and distressing side
effect of cancer chemotherapy and radiotherapy. Almost
every patient with oral cancer treated with chemo-
radiotherapy develops deep and painful wounds as the
characteristic of this condition [1]. The wounds often
affect the gastrointestinal mucosa, and mucositis can,
therefore, results in severe discomfort and reduction in
patient's ability to eat, swallow and speak [2]. Radiation* Correspondence: mmotallebnejad@yahoo.com
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reproduction in any medium, provided the ortherapy leads to the production of free radicals and sub-
sequent oxidative stress, thereby causing damage to cells
and their function. It seems that radiotherapy-induced
oxidative stress can also affect the salivary antioxidant
capacity [3].
Cinnamon, scientifically named Cinnamomum spp, is
a plant with many uses as a herbal medicine, containing
mucilage, tannin, sugar, resin, and essential oil, among
which the essential oil is the most important part, a
substantial portion of which is made up of cinnamalde-
hyde or cinnamic aldehyde [4]. In traditional medicine,
various therapeutic uses have been proposed for this
plant [5-7]; besides, it has been found to have high anti-
oxidant [8], anti-bacterial [9], and anti-inflammatory
[10] activity which also play a role in tissue repair [11].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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or prevention of mucositis, and the recent evidences
suggest that cryotherapy, benzydamine, corticosteroid
[2], GM-CSF [12], amifostine [2,13] and palifermin
[2,14] may be helpful in certain situations via blood ves-
sels contraction, anti-inflammatory and local anesthetic
effects, anti-inflammatory properties, and cytoprotec
tive mechanism respectively. Therefore, regarding the
pharmacologic effects of cinnamaldehyde, the present
study aimed at investigating the antioxidant property of
cinnamaldehyde on the rats' saliva and its clinical effects
on mucositis.
Methods
The present experimental study was carried out on
28 male albino Wistar rats,(7 to 11& 160 ± 20 g),
selected through simple random sampling from the
Animal Care Center of Babol University of Medical
Sciences. The project was approved by the Research
Council as well as the Research Ethics Committee of
Babol University of Medical Sciences (ORN: 1050).
Prior to the study, all animals were kept under the
same laboratory condition at 21 ± 1°C and 12:12 h
light/dark cycle with same access to food and water
supply [15]. Cinnamaldehyde 98% (Merk, Germany)
was used in the present study. Rats were divided into
four groups of seven rats each, The first group receiv-
ing normal saline (S), the second group receiving sa-
line and gamma radiation (SR), the third group
receiving 50 mg/kg cinnamaldehyde 98% (C), and the
fourth group receiving 50 mg/kg cinnamaldehyde 98%
and gamma radiation (CR).
A pilot study was conducted to observe the process
of radiation, radiation induced-mucositis onset, deter-
mination of the maximum radiation effects (sixth day)
and recovery from mucositis (tenth day). Prior to the
radiation, all rats were marked and weighed. Normal
saline was then injected to S and SR groups and cin-
namaldehyde to C and CR groups as the first intraperi-
toneal(ip) injection. On the same day, animals were
partially anesthetized with midazolam (25 mg/kg), and
pilocarpine 0.5 mg/kg was injected ip to obtain the sal-
iva samples. Fifteen minutes later, saliva samples were
taken using a sampler and collected in 0.5 ml micro-
tubes. In the afternoon, the CR and SR groups were
transferred to Shahid Rajai hospital of Babolsar for re-
ceiving the radiation. The animals were anesthetized by
ketamine (100 mg/kg) ip before the radiation; they
were completely immobilized on a special shield and
exposed dosage 15 Gy gamma radiation (16Co and
1.25 million electron volts energy using Teraton780) at
a for 7 min and 39 s. The tube placement was set in
the way that the rats' whole cranium was in the field
[15]. At the end of radiation, rats were returned to theAnimal Care Center of Babol University of Medical
Sciences and were daily weighted during the 10-day
experimental period; the relative groups were intraperi-
toneal injected afterwards and their tongues and lips
were examined for the signs of mucositis using Par-
kin's clinical scale [16] (scale 0, normal; scale 0.5,
slightly pink; scale 2, extremely red; scale 3, local des-
quamation; scale 4, exudation and crust less than one-
half of the lip; scale 5, exudation and crust more than
one-half of the lip). On the sixth day of the experi-
ment, as the mucositis peak (according to the pilot
study), saliva samples were taken using the mentioned
approach. On the last day of the study (the 10th day),
improvement was evident in mucositis and radiation-
induced effects. Saliva samples were collected one
more time on this day, and the animals were sacrificed
after anesthesia.
Salivary analysis
The saliva samples prepared on days zero, six and ten,
kept at −20°C in the freezer, were transported to the la-
boratory and underwent centrifugation at 3000 rpm for
15 min and supernatant transferred to the test tubes
after deposition of saliva impurities, and the total anti-
oxidant activity was calculated using the FRAP (Ferric
reducing antioxidant power) technique [17]. In this
method the reduction of Fe3+ to Fe2+ is seen in the pres-
ence of antioxidants. In sum, FRAP reagent contains
TPTZ (2, 4, 6-tripyridyl-s-triazine; sigma) 10 mmol/L in
40 mmol/L HCL plus FeCl3 20 mmol/L and buffer acet-
ate 0.3 mol/L (PH: 3.6) in the ratio of 10:1:1; the reagent
was freshly prepared and heated for 5 min at 37°C. The
working FRAP reagent (1.5 ml) was mixed with 50
microliter of serum. After 10 min at 37°C, the absorp-
tion was read at 593 nm and compared with the stand-
ard. FeSo4 (125, 250, 500, and 1000 μmol/L) was
considered as the standard solution, based on which the
standard curve was plotted [18].
Statistical analysis
Data are presented as the mean (±SD) in the tables and
figures. For weight comparison, one-way ANOVA was
used along with post-hoc Bonferroni. Mucositis-related
data were also analyzed by one-way ANOVA. To com-
pare the severity of mucositis between the treatment
groups, Mann–Whitney was applied between each two
groups. Data related to the salivary antioxidant capacity
were analyzed by one-way ANOVA as well. P-value
<0.05 was considered significant.
Results
The present study was conducted on 28 Wistar rats,(7–
11, 160 ± 20 g) divided into four groups of seven rats
Figure 1 Alteration of mucositis in the CR and SR groups during the days of experiment.
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period and received the relative daily injections.
Mucositis
The mean mucositis onset was 2.43 ± 0.2 days in the SR
and 4.14 ± 1.6 days in the CR groups, so as mucositis
appeared significantly later in CR than the SR group
(P = 0.024, T-test).
The results revealed that the scale of mucositis was
higher in SR compared to the CR group, and the differ-
ence was significant on the second day of the experiment
(Mann–Whitney test, p = 0.027) (Figure 1, Table 1).
Antioxidant
Salivary antioxidants concentration showed no signifi-
cant difference between the study groups on day zero
(one-way ANOVA, p > 0.05). On the sixth day, the con-
centration of saliva antioxidant was significantly higher
in CR compared to S group (one-way ANOVA, P =
0.017); however, salivary antioxidant concentration was
remarkably higher in C compared to S, SR, and CR
groups on the tenth day of experiment (one-way
ANOVA, P <0.05) (Figure 2, Table 2).
Weight
The mean (±SD) weight change was 25.71 ± 9.53, -4.7 ±
31.1, -1 ± 11.4, and 11.42 ± 7.27 in the S, SR, C, and CR
groups respectively. There was a significant weight gain
in S compared to the C group (T-test, p = 0.042);Table 1 The mean (±SD) scale of mucositis in SR and CR grou
Days 0 1 2 3 4 5
Mucositis
SR 0.00 0.00 0.56 ± 0.44 1.00 ± 0.76 2.00 ± 0.81 3.57 ±
CR 0.00 0.00 *0.07 ± 0.18 0.35 ± 0.47 1.00 ± 1.00 1.14 ±
*Mann–Whitney test, p = 0.027.similarly, the CR group showed a higher weight gain
than the SR (T-test, P = 0.338), as well as the C group
(T-test,p = 0.56).
Discussion
In the present research, the effect of cinnamaldehyde
has been investigated on mucositis and total salivary
antioxidant capacity (TAC) in gamma-irradiated rats.
Several studies have addressed to evaluate the anti-
inflammatory, antibacterial and antioxidant effects of
cinnamaldehyde. Reduction in the production of pros-
taglandin E2 and inhibition of cyclooxygenase-2 (COX-
2) expression and subsequent significant decrease in
Interleukin-1ß [19], increase in glutathione peroxidase
activity [20], and bactericidal activity against Strepto-
coccus [21] and Staphylococcus species, lactobacilli
[17], and other gram positive and negative bacteria
[22] are the results brought about as the effect of cin-
namaldehyde. Clinical findings of the present study
showed a significantly delayed onset of mucositis in
CR than the SR group, and in terms of the mucositis
severity, the difference of scale of mucositis was statis-
tically significant on the second day of the experiment
in the CR group. The clinical anti-mucositis effects
were evident in CR compared to the SR group. Muco-
sitis begins with inflammatory phase and continues
with ulcerative and bacteriological phase [14]; On the
other hand, radiotherapy leads to the induction of oxi-
dative stress, thereby resulting in tissue damage [3];ps in the days of experiment
6 7 8 9 10
0.44 3.71 ± 1.11 3.28 ± 0.95 2.57 ± 1.27 1.28 ± 0.95 0.14 ± 0.37
1.77 3.07 ± 1.69 3.00 ± 1.41 3.00 ± 1.41 1.71 ± 1.41 0.14 ± 0.37
Figure 2 Total salivary antioxidant capacity (TAC) in the study
groups.
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and antioxidant mechanisms, cinnamaldehyde may
delay the onset of mucositis. Moreover, alteration in
oral microflora including the appearance of Streptococ-
cus mutans, lactobacilli and gram-negative bacilli in
the bacteriological phase can aggravate the severity of
mucositis [14], and it seems that cinnamaldehyde can
cause clinical influence on mucositis via its antibacter-
ial properties; this conclusion, however, requires fur-
ther and more accurate investigation. In addition,
study on a greater number of samples in each group
can perhaps describe the difference in the severity of
mucositis between the two groups more precisely on
more days during the ten-day period.
In a study by Gowder et al., it has been shown oral
administration of cinnamaldehyde has a delayed effect
on serum antioxidant of the rat's kidney tissue follow-
ing passing through the liver metabolism, so as it con-
tributes to an increase in antioxidants such as
superoxide desmotase, glutathione proxidase, and
glutathion-s-transferase [20]. The results achieved from
the analysis of salivary antioxidant capacity indicated a
significantly higher level of TAC in C compared to the
other groups only on the tenth day of the experiment.
It appears that ip injection of cinnamaldehyde may
have a delayed effect on salivary TAC, the exactTable 2 The mean (±SD) salivary antioxidant capacity (μM) in
Groups CR C
Days
0 74/69 ± 813/50 315/23 ± 744/
6 146/66 ± 681/79 280/40 ± 439/
10 71/08 ± 606/23 150/73 ± 605/mechanism of which is not yet clear. Therefore, it is
recommended that to shed light on the relative mech-
anism, studies be conducted in a longer period of time;
the prophylactic use of cinnamaldehyde is also sug-
gested to be initiated several days before the radiation
and the antioxidant effects be evaluated during irradi-
ation to benefit from antioxidant effects of cinnamalde-
hyde on mucositis improvement, since there are bodies
of evidence indicating the delayed and time-dependent
properties of cinnamaldehyde [20].
TAC demonstrated a decreasing trend in the CR group
during the ten-day study period; nonetheless, it showed
an increase compared to the SR group in mutual com-
parison between the study groups, as salivary antioxidant
concentration was higher in CR than the SR group al-
though the difference was not statistically significant.
Regarding the radiotherapy-induced oxidative stress
which may lead to DNA damage and loss of acinar pre-
cursors of the salivary glands [3], reduced TAC in the
CR group might be due to damage to the salivary glands
[3], as well as delayed and time-dependent effect of cin-
namaldehyde [20]. Although, it is not clear that the oxi-
dative stress induced by ionizing radiation on malignant
cells may be faded by the anti-oxidative effects of cinna-
maldehyde or any other remedies which have been sug-
gested to be protective for normal tissues [23].
In the examination of weight change, a significant in-
crease was observed in S compared to the C group; such
a weight loss in the latter can be ascribed to the allergic
and toxic nature of cinnamaldehyde [24] in comparison
with the safe injection of normal saline. The weight
change has not been statistically significant in the other
groups.
In the end, it is suggested that further researches be
implemented to assess the clinical and histopathological
effect of cinnamaldehyde on radiotherapy-induced
mucositis and the relative mechanisms.
Conclusion
The clinical effects in the CR group seem to be due to
antioxidant, anti-bacterial and anti-inflammatory effects
of cinnamaldehyde; this conclusion, however, requires
further investigations. Delayed antioxidant effect in the
CR group was evident in ip cinnamaldehyde injection,
the exact mechanism is not clear.the four groups on days zero, six and ten
SR S
94 187/40 ± 344 29/151 ± 348/86
23 194/51 ± 527/5 17/67 ± 345/71
23 90/49 ± 230/94 62/90 ± 244/38
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